ATI Physical Therapy, Inc. (ATIP)
NYSE: ATIP · IEX Real-Time Price · USD
4.050
-0.018 (-0.45%)
Apr 23, 2024, 3:47 PM EDT - Market closed
ATI Physical Therapy Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ATIP.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ATIP.
Recommendation Trends
| Rating | Jun '22 | Jul '22 | Aug '22 | Sep '22 | Oct '22 | Nov '22 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 1 | 1 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 3 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Maintains $100 → $33 | Hold | Maintains | $100 → $33 | +702.47% | Nov 16, 2022 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 10, 2022 |
| Citigroup | Citigroup | Hold Maintains $70 → $60 | Hold | Maintains | $70 → $60 | +1,381.48% | Nov 8, 2022 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 27, 2022 |
| Benchmark | Benchmark | Strong Buy Maintains $200 → $100 | Strong Buy | Maintains | $200 → $100 | +2,369.14% | Aug 10, 2022 |
Financial Forecast
Revenue This Year
765.71M
from 699.02M
Increased by 9.54%
Revenue Next Year
812.53M
from 765.71M
Increased by 6.11%
EPS This Year
-14.98
from -31.93
EPS Next Year
-12.33
from -14.98
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 788.3M | 837.3M |
| Avg | 765.7M | 812.5M |
| Low | 735.6M | 779.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 12.8% | 9.3% |
| Avg | 9.5% | 6.1% |
| Low | 5.2% | 1.9% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -15.42 | -12.69 |
| Avg | -14.98 | -12.33 |
| Low | -14.40 | -11.85 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.